This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit December 23, 2014

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

As 2014 comes to a close, ASCT would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of ASCT Viewpoint a look at the most accessed articles from the year. Our regular publication will resume Jan. 6.


The end of the Pap test? FDA to decide
WebMD
From March 26: Is the Pap test going the way of car phones and Walkmans? Pap tests are used to find early signs of cervical cancer. But over the past several years, studies from a number of countries have found that HPV tests are better than the Pap test at finding cervical cancer. While HPV tests have been on the market for more than a decade, they are approved only for use along with the Pap test.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


A single algorithm is phasing out the Pap smear
The Verge
From May 14: But the FDA's new approval of HPV testing changes two distinct features of how the test is used and promoted: It permits the use of an algorithm that enables the HPV test to be used on its own, and allows Roche to market its HPV test directly to consumers. Combined, those factors could spell the end of the Pap smear as we know it — a move that opponents say adds unnecessary confusion to an already complicated screening process, and jeopardizes women's health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Mushrooms can fight cervical cancer
KHOU-TV
From April 9: A recent study indicates that mushrooms can help fight cervical cancer. In the study, researchers treated cervical cancer cells with AHCC, which is a proprietary extract made from the thread-like part of the mushroom. Researchers were able to suggest that AHCC can eliminate HPB infections and may have a role in the prevention of HPV-related cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Clinical trial provides women with more accurate way to detect cervical cancer
News-Medical
From Aug. 13: Jersey Shore University Medical Center is conducting a clinical trial that provides women with a more accurate way to detect cervical cancer. The clinical research study, led by Mark Martens, M.D., chair of Obstetrics & Gynecology at Jersey Shore University Medical Center and world renowned expert in women's health, includes a free Pap test and HPV screening that more effectively evaluates a woman's chance of developing cervical cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Urine-based HPV test 'feasible alternative for cervical cancer screening'
Medical News Today
From Sept. 24: A new study published in The BMJ claims that a simple urine test for human papillomavirus — the main cause of cervical cancer — could increase screening uptake among women by offering them a non-invasive option.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


UPCOMING EVENTS

Date Event Location More information
Jan. 14, 2015
2 p.m. EST
Quality Assurance Planning: A Practical Approach to Quality Management Systems Madison, WI


John Shalkham, SCT(ASCP), Manager, Disease Prevention Division Director, Office of Quality Assurance, Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison,
More info |

Jan. 17, 2015

Arizona Cytology Association Annual Conference

Gilbert, AZ

MD Anderson Center
Save the date! More information to follow in a future ViewPoint
Feb. 11, 2015
2 p.m. EST
Cytohistology of Pulmonary Neuroendocrine Tumors Atlanta, GA


Momin T. Siddiqui, M.D., Professor of Pathology, Director of Cytopathology, Emery University Hospital
More info |
March 11, 2015
2 p.m. EST
CPTs and ICDs: Understanding the Basics of Cytology Billing Pittsburgh, PA


Jackie Cuda, BS, SCT(ASCP), Cytology Supervisor, University of Pittsburgh Medical Center Pittsburgh, PA
More info |

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


Should HPV testing replace the Pap?
NPR
From May 28: For years, doctors have been using the Pap smear to screen for cervical cancer. The Pap involves swabbing some cells from a woman's cervix to examine them for any signs of abnormalities. It's credited with a steep decline in the number of cases of cervical cancer in the United States — and a drop in deaths from the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Are routine pelvic exams 'more harm than good' for healthy women?
Medical News Today
From July 9: The pelvic exam is a standard part of women's gynecologic checkup, but a new review by the American College of Physicians shows that for healthy women it is likely doing more harm than good, causing the doctors' group to issue a new guideline that advises against it. The new guideline, plus a report on the supporting evidence review, are published in the Annals of Internal Medicine, along with an editorial comment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Rates of cervical cancer are underestimated
TIME
From May 28: Rates of cervical cancer are higher than previously reported, according to a new study, specifically among older women and black women. Previous estimates put the rate of cervical cancer at 11.7 per 100,000 women, with prevalence peaking for women between ages 40 and 44. But most of those estimates included women who had hysterectomies, which removes the uterus and cervix, making it impossible for those women to get cervical cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of ASCT Viewpoint? Click here to visit the ASCT Viewpoint archive page.


FDA approves new HPV screening method
Medical Daily
From May 14: The Food and Drug Administration has approved the first human papillomavirus test for primary cervical cancer screening: cobas. The test is for women 25 and older, and it can be used alone as a first step to decide if a woman needs additional testing to determine if she has cervical cancer. It can also be used to assess risk factors for developing cancer in the future.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cervical cancer prevention program saves lives
CFAH
From July 23: A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 10, 2014
Nov. 26, 2014
Nov. 12, 2014
Oct. 22, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063